PMID: 8945493Dec 1, 1996Paper

Cyclosporine in the treatment of dermatologic disease: an update

Mayo Clinic Proceedings
K K LimM R Pittelkow

Abstract

Treatment with cyclosporine is beneficial for many dermatologic diseases such as psoriasis, lichen planus, Behçet disease, atopic dermatitis, pyoderma gangrenosum, and epidermolysis bullosa acquisita. The selective action of cyclosporine on helper T cells and its rapid therapeutic action and weak myelotoxicity are the key advantages in the treatment of many dermatologic diseases. Nevertheless, drug toxicity, especially nephrotoxicity, high rates of relapse after treatment cessation, and high cost have limited its use to those diseases refractory to other therapies. Herein we discuss the use of cyclosporine for dermatologic diseases relative to efficacy, dosage, safety profile, and monitoring. In addition, we review the formulations and metabolism of cyclosporine; discuss its mechanism of action, clinical indications in dermatology, and side effects; and provide usage guidelines for this drug. Cyclosporine can be safely administered when potential toxicities, dosing, and monitoring guidelines are known.

References

Oct 1, 1992·Journal of the American Academy of Dermatology·K JitsukawaH Radloff
Jan 1, 1992·Clinical and Experimental Dermatology·M J Korstanje
Nov 1, 1992·The British Journal of Dermatology·M J KorstanjeT J Stoof
Nov 1, 1992·Journal of the American Academy of Dermatology·J GardeazábalJ L Diáz-Pérez
Nov 1, 1991·The British Journal of Dermatology·U Mrowietz, E Christophers
Dec 1, 1991·International Journal of Dermatology·P CampolmiE Panconesi
Jan 31, 1991·The New England Journal of Medicine·C N EllisT G Parish
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B E BiererS L Schreiber
Feb 1, 1990·Journal of the American Academy of Dermatology·A K GuptaJ J Voorhees
Aug 2, 1990·The New England Journal of Medicine·D EisenJ J Voorhees
Jun 1, 1990·The British Journal of Dermatology·M S FradinJ J Voorhees
Jun 1, 1990·The British Journal of Dermatology·G FeutrenB von Graffenried
Sep 1, 1990·Journal of the American Academy of Dermatology·R U PeterO Braun-Falco
Nov 1, 1990·Journal of the American Academy of Dermatology·M S FradinJ J Voorhees
Dec 1, 1990·Journal of the American Academy of Dermatology·V C HoD I McLean
Dec 1, 1990·Journal of the American Academy of Dermatology·M S FradinJ J Voorhees
Dec 1, 1990·Journal of the American Academy of Dermatology·G MockliT W Kurtz
Dec 1, 1990·Journal of the American Academy of Dermatology·P B Watkins
Jan 1, 1990·Journal of the American Academy of Dermatology·V C HoJ J Voorhees
Jan 1, 1990·Journal of the American Academy of Dermatology·V C HoJ J Voorhees
May 13, 1989·Lancet·J HeckmattV Dubowitz
Dec 21, 1989·The New England Journal of Medicine·B D Kahan
Aug 1, 1989·Journal of the American Academy of Dermatology·P G NorrisJ L Hawk
Sep 1, 1989·Journal of the American Academy of Dermatology·S C GilbertG Klintmalm
Sep 1, 1989·Journal of the American Academy of Dermatology·R S TaylorJ J Voorhees
Apr 4, 1987·Lancet·C E GriffithsH Valdimarsson
Sep 20, 1986·British Medical Journal·C E GriffithsH Valdimarsson
Jan 1, 1988·Clinical and Experimental Dermatology·C FrancèsP Godeau
Jun 1, 1988·Journal of the American Academy of Dermatology·H BarthelemyJ Thivolet
Jan 1, 1995·Clinical and Experimental Dermatology·J Berth-JonesR A Graham-Brown
Oct 1, 1994·Oral Surgery, Oral Medicine, and Oral Pathology·A B VoûteI van der Waal
Jan 1, 1995·Journal of the American Academy of Dermatology·G MahrleG K Steigleder
Mar 1, 1994·Journal of the American Academy of Dermatology·R FiloticoG Angelini
Mar 1, 1994·The British Journal of Dermatology·C S MunroP S Friedmann
Feb 1, 1994·International Journal of Dermatology·A B Kauvar, M J Stiller
May 1, 1994·Journal of the American Academy of Dermatology·M LapidothM Sandbank
May 1, 1994·The Journal of Clinical Investigation·J B RoulletW M Bennett

❮ Previous
Next ❯

Citations

Feb 27, 2003·Veterinary Dermatology·David C Robson, Gregory G Burton
Mar 25, 2004·Nature Reviews. Immunology·Thomas S Kupper, Robert C Fuhlbrigge
Nov 23, 2019·Current Drug Delivery·Arya Kadukkattil RamanunnyAnkit Awasthi
Oct 23, 1998·Journal of the European Academy of Dermatology and Venereology : JEADV·O AvciA T Guneş
Feb 20, 2003·International Journal of Immunopathology and Pharmacology·C. Feliciani, A. Tulli
Jan 5, 2002·American Journal of Clinical Dermatology·S M Cheer, G L Plosker
Nov 30, 2000·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·M AlamA I Benvenisty
Dec 6, 2005·Nature Clinical Practice. Gastroenterology & Hepatology·Simon CampbellDerek P Jewell
Mar 11, 2004·Journal of the European Academy of Dermatology and Venereology : JEADV·M García-BustínduyR García-Montelongo
May 20, 2003·The British Journal of Dermatology·G G Krueger, C N Ellis
Jun 10, 2000·Alimentary Pharmacology & Therapeutics·P J WahabC J Mulder
Aug 17, 2005·International Journal of Dermatology·John C Maize, Jack B Cohen
Nov 1, 2007·Current Medical Research and Opinion·M L Levy
Nov 10, 2004·International Journal of Dermatology·W P Daniel SuHarold O Perry
Jun 18, 2021·Psoriasis : Targets and Therapy·Yang Lo, Tsen-Fang Tsai
Apr 20, 2005·Dermatologic Clinics·Dana Kazlow SternMark Lebwohl
Jan 13, 2001·Dermatologic Clinics·J C CatherA Menter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Related Papers

International Journal of Immunopathology and Pharmacology
C. Feliciani, A. Tulli
The British Journal of Dermatology
C E M GriffithsK Thestrup-Pedersen
© 2021 Meta ULC. All rights reserved